Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Hydrochloric Acid | HCID 313 | — |
| Reactant | Sodium Hydroxide | HCID 14798 | — |
| Reactant | Borane;tetrahydrofuran | HCID 2723981 | — |
| Reactant | HCID 86724072 | HCID 86724072 | — |
| Solvent | Tetrahydrofuran | HCID 8028 | — |
| Product | HCID 86724075 | HCID 86724075 | 56% |
Reaction Steps
To a solution of methyl 2-[4-(2,4-dichlorophenyl)-1-methyl-7-oxo-3-(2-pyridyl)-4H-pyrazolo[3,4-e][1,4]thiazepin-8-yl]acetate (1.18 g, 2.5 mmol, Preparation #9) in anhydrous THF (50 mL) was added a solution of borane THF complex (9.90 mL, 1M in THF, 4 mmol, Acros), the resulting mixture was stirred at rt for about 16 h and then for about 4 h at about 50° C. After cooling to about 4° C., 6 M aqueous HCl (10 mL) was added dropwise and the mixture stirred for about 45 min at rt. Subsequently, the mixture was cooled again to about 4° C., treated with 2 M aqueous NaOH (35 mL) and extracted with ethyl acetate (75 mL). The organic layer was dried (MgSO4), filtered and concentrated in vacuo. The residue was purified by column chromatography (SiO2, ethyl acetate/DCM 1:1 and ethyl acetate) to give methyl 2-[4-(2,4-dichlorophenyl)-1-methyl-3-(2-pyridyl)-6,7-dihydro-4H-pyrazolo[3,4-e][1,4]thiazepin-8-yl]acetate (0.65 g, 1.4 mmol, 56%) as a white foam, which was used as such: LC-MS (Table 1, Method d) Rt=2.90 min; m/z 463 (M+H)+
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US09150592B2 |
|---|
| Source dataset | uspto-grants-2015_10 |
|---|
| ORD ID | ord-9f88b18615f543b1b6471bb4b81fa848 |
|---|
| Source note | uspto-grants-2015_10 |
|---|